Home : Technology Transfer : Intellectual Property Office : Patents : Medical Processes & Devices

Intellectual Property Office

Patents Issued

Medical Processes & Devices

1999

  • US 5,855,913 Particles Incorporating Surfactants for Pulmonary Drug Delivery
  • US 5,856,085 Compositions and Methods of Developing Oligonucleotides and Oligonucleotide Analogs Having Antiviral Activity
  • US 5,874,064 Aerodynamically Light Particles for Pulmonary Drug Delivery
  • US 5,914,269 Oligonucleotide Inhibition of Epidermal Growth Factor Expression
  • US 5,916,894 Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines
  • US 5,919,456 IL-13 Receptor Specific Chimeric Proteins
  • US 5,958,932 Substituted O6 Benzylguanine, Compositions, and Methods of Using Same
  • US 5,965,126 Use of Mutant Alkyltransferases for Gene Therapy to Protect from Toxicity of Therapeutic Alkylating Agents
  • US 5,968,748 Antisense Oligonucleotide Modulation of Humas Her-2 Expression
  • US 5,985,309 Preparation of Particles for Inhalation
  • US 5,994,115 Artificial System for the Production of Infectious Human Papillomavirus

2000

  • US 6,020,396 A New Bond Cement Formulation with an Enhanced Fatigue Lifetime
  • US 6,060,481 Use of A2b Adenosine Receptor Antagonists for the Treatment of Noninsulin-Dependent Diabetes Mellitus and Impaired Glucose
  • US 6,060,458 Oligodeoxyribonucleotides Comprising O6-Benzylguanine And Their Use
  • US 6,059,742 Negative Pressure Chest Brace
  • US 6,106,551 Communication Method For Implantable Medical Device
  • US 6,110,663 Methods For Detecting, Titering, And Determining Susceptibility To Papillomavirus
  • US 6,136,295 Aerodynamically Light Particles For Pulmonary Drug Delivery
  • US 6,136,780 Control Of Cancer Growth Through The Interaction Of [MET5]-Enkephalin And The Zeta (_) Receptor
  • US 6,156,503 Diagnosing Asthma Patients Predisposed To Adverse _-Agonist Reactions
  • US 6,156,504 Detection Of Extra Cellular Tumor-Associated Nucleic Acid In Blood Plasma Or Serum Using Nucleic Acid Amplification Assays

2001

  • US 6,172,070 Substituted 06-Benzylguanines and 6(4) - Benzyloxypyrimidines
  • US 6,183,423 Obstructive Sleep Apnea Prescreening Procedure
  • US 6,192,887 A Broad Spectrum Microbicide Against Enveloped and Non-enveloped Viruses
  • US 6,200,745 In Vitro Test for Anti-Papillomavirus Drugs
  • US 6,201,039 Resorbable Synthetic Bone
  • US 6,235,061 Polyorganophsophazene Matrices for Bone Replacement
  • US 6,254,854 Light Particles for Pulmonary Delivery
  • US 6,271,359 Tissue-Specific and Pathogen-Specific Toxic Agents and Ribozymes
  • US 6,296,843 Mutagenesis of Interleukin 13 Which Leads to a More Discriminate Recognition of its Receptor on Cancer Cells
  • US 6,303,604 Substituted 06-Benzylguanines and 6(4) - Benzyloxypyrimidines
  • US 6,309,848 Artificial Human Vagina for Testing Topical Microbicides
  • US RE37,053E Particles Incorporating Surfactants for Pulmonary Drug Delivery

2002

  • US 6,455,246 Artificial Human Vagina for Testing Topical Microbicides
  • US 6,436,633 Artificial Human Vagina for Testing Topical Microbicides
  • US 6,479,232 Artificial Human Vagina for Testing Topical Microbicides
  • US 6,428,788 Cancer-Specific Receptor for Interleukin 13
  • US 6,432,136 Magnetic Catheter Guidance and Proximity-Measuring Device
  • US 6,337,052 Specimen Temperature Stabilizing Device
  • US 6,395,027 Method of Communication with Implanted Blood Pump Recipient
  • US 6,458,346 A Broad Spectrum Microbicide Against Enveloped and Non-enveloped Viruses
  • US 6,436,945 Substituted 06-Benzylguanines and 6(4) - Benzyloxypyrimidines
  • US 6,458,164 Method for Energy Recovery in a Resonant Converter Transcutaneous Energy Transmission System
  • US 6,451,055 Method for Data Transmission Via a Transcutaneous Energy Transmission
  • US 6,478,820 Method for Synchronous Rectification in a Transcutaneous Energy Transmission System
  • US 6,436,443 Light Particles for Pulmonary Delivery
  • US 6,447,753 Light Particles for Pulmonary Delivery
  • US 6,447,752 Light Particles for Pulmonary Delivery
  • US 6,399,102 Light Particles for Pulmonary Delivery

2003

  • US 6,537,993 Phenoxymethylquinoxalinone Compounds, Compositions and Methods for Enhancing Chemotherapy
  • US 6,511,805 Method for Detecting Mutant Oncogenes in Blood
  • US 6,521,409 Method for Detecting Mutant Oncogenes in Blood
  • US 6,630,301 Method for Detecting Mutant Oncogenes in Blood
  • US 6,518,061 Cancer-Specific Receptor for Interleukin 13
  • US 6,610,471 Use of Baculovirus Constructs Containing Hepatitis Virus DNA in Cells of Hepatic Origin
  • US 6,579,315 Method for Subharmonic Excitation of a Resonant Converter Transcutaneous Energy Transmission System
  • US 6,533,739 Inexpensive Medical Device to Support Neonatal Respiration
  • US 6,561,192 The NORI System
  • US

2004

  • US 6,693,112 Phenoxymethylquinoxalinone Compounds, Compositions and Methods for Enhancing Chemotherapy
  • US 6,815,442 Phenoxymethylquinoxalinone Compounds, Compositions and Methods for Enhancing Chemotherapy
  • US 6,682,545 In situ Delivery of Ceramide Analogues as a Novel Preventive Therapy for Restenosis
  • US 6,685,724 Port-less Laparoscopy Systems
  • US 6,770,022 Magnetic Stimulation of Muscles for Relief of Obstructive Sleep Apnea
  • US 6,810,878 The NORI System

2005

  • US 6,878,524 80-Trap Two-Hybrid Assay a Novel System for Detecting Protein Protein Interactions In vivo
  • US 6,884,603 Mutagenesis of Interleukin 13 Which Leads to a More Discriminate Recognition of its Receptor on Cancer Cells
  • US 6,929,922 Distribution of Transferrin and Ferritin Binding in Normal and Multiple Sclerotic Human Brains
  • US 6,969,583 An Assay for Detecting Variant Hepatitis B Viruses
  • US 6,884,581 Constitutive AP-1 Activation is a Major Causative Factor for Malignant Gliomas Progression
  • US 6,939,675 Method for Detecting Mutant Oncogenes in Blood
  • US 6,951,546 Inexpensive Medical Device to Support Neonatal Respiration

For more information, please send e-mail to the Intellectual Property Office or contact a member of our staff .